Shenzhen Ruifa Biotechnology Co., Ltd., established on 2020-07-14, Business scope includes general business items:Natural science research and experimental development;Engineering Technology Research and Experimental Development;Medical Research and Experimental Development;Development and technical consultation of biotechnology and medical technology,technology transfer;Gene Technology Development,technical consulting,technology transfer;Health management consulting and services related to human diseases and physical conditions;Domestic Trade;Engaged in the import and export of goods and technology;Information Consulting(No restricted items);Business Management Consulting(No restricted items);Invest in business.,The licensing program is:Engaged in scientific research equipment,medical instruments,Diagnostic reagents,Gene detection reagents,medicine,biological reagent,Enzyme reagents and biochemical reagents(Free of Hazardous and Toxic Chemicals)research and development,Production and agency of the above products,Sales,technical consulting,Technical Services,Import and export and related supporting business;Network technology development,Technology development and sales of computer software and hardware;First,two,Three types of medical device research and development,production and sales.

The Eli and Edythe L. Broad Institute of MIT and Harvard (/ˈbroʊd/), often referred to as the Broad Institute, is a biomedical and genomic research center located in Cambridge, Massachusetts, United States. The institute is independently governed and supported as a 501(c)(3) nonprofit research organization under the name Broad Institute Inc., and is partners with Massachusetts Institute of Technology, Harvard University, and the five Harvard teaching hospitals.

Jiaohong Biology is used in the fields of precise diagnosis of tumours, nucleic acid detection of epidemic viruses, nucleic acid detection of animal and plant diseases, and food safety. It is a provider of molecular diagnostic technology research, development, and application services.

Beijing Aige Stem Cell Technology Co., Ltd., established on 2020-12-28, Business scope includes technology development,Serve,consult,transfer;Retail Medical Devices(limit Ι,Class II);sell cosmetics,Office Supplies,Electronic equipment,Instrumentation,Chemical Products(Does not contain dangerous chemicals and a class of precursor chemicals);Technology Import and Export;Import and export;wholesale medicine;retail medicine.(Market entities independently choose business projects in accordance with the law,Carry out business activities;wholesale medicine,Retail pharmaceuticals and items subject to legal approval,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Genetron Health is a world-leading expert in precision medicine.They are committed to developing health management products that cover all elements of full-cycle cancer clinical treatment (including risk assessment, early screening, molecular pathology diagnosis, medication guidance and prognosis monitoring) and effectively applying genomic data to assist medical experts and research scientists. Additionally, they provide cancer patients and high-risk and healthy individuals with reliable molecular clinical services and professional cancer genetic risk assessment.In just three years, Genetron Health has built global genomics sequencing and bioinformatics platforms, established two research and development centers in both North Carolina, U.S., and Beijing, China, and set up clinical laboratories in Beijing, Shanghai, Hangzhou and Chongqing of over 10,000 square meters.In the future, Genetron Health will spread its sales network throughout China with professional marketing, product management, medical experts and scientific research teams, and will provide service for Chinese and global cancer patients with its strong foundation in cancer genomics and efficient clinical translation.

Boya Jiyin (Beijing) Biotechnology Co., Ltd., established on 2016-03-21, Business scope includes technical promotion services;Natural science research and experimental development,Medical Research and Experimental Development;Technology Import and Export,Import and export,Agent import and export;Sales of biological reagents(Free of Hazardous Chemicals,medicine),Chemical Products(Free of Hazardous Chemicals).(Market entities independently choose business projects in accordance with the law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Guizhou Provincial People's Hospital is a private company headquartered in Guiyang, China, that provides medical services.

The 301 Hospital (Chinese: 三〇一医院) or People's Liberation Army General Hospital (Chinese: 中国人民解放军总医院), which constitutes simultaneously the PLA Postgraduate Medical School (Chinese: 中国人民解放军医学院), located in Beijing, China, is a military hospital directly subsidiary to Logistic Support Department of the Central Military Commission and the largest general hospital under the auspices of the People's Liberation Army. Its mission includes assuring the health of PLA and China's leaders.

Suzhou Genga Biomedical Engineering Co., Ltd., established on 2016-08-26, Business scope includes biomedicine,R&D of medical devices,Production,Sales;biotechnology development,technical consulting,technology transfer,Technical Services;laboratory consumables,laboratory reagent,Instrumentation(Does not include measuring instruments),computer,Sales of software, hardware and auxiliary equipment;Engage in the import and export of the above commodities and technologies.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments) General project:Machinery and Equipment Leasing;Medical equipment rental;Non-residential real estate leases(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Beijing Academy of Agriculture & Forestry Sciences is a Chinese private company with domestic subsidiaries, that operates as an agricultural research organization.

Part of Genetron Holdings Ltd., Genetron Health (Beijing) Co., Ltd. is a company headquartered in China. The firm manufactures health management products for cancer clinical treatment.

Hypros is the world's leading high-tech enterprise in precision medical and genetic big data. The company is committed to integrating cutting-edge emerging technologies such as liquid biopsy, gene sequencing, artificial intelligence, and big data. It focuses on the whole process of diagnosis and treatment of cancer patients, and is determined to use technology to improve the quality of life and make every life healthy for 120 years. Hypros has completed the multi-center globalization of Shenzhen R&D Headquarters, Third-Party Medical Laboratory, GMP Production Workshop, US R&D Center, Hypus Genome Center and Shangrao International Precision Medical Health Industrial Park. The company invested hundreds of millions of dollars to introduce the world's most advanced Illumina NovaSeq6000, HiSeq X Ten, NextSeq500/550 series sequencing platform and digital PCR platform, successfully built the world's top genetic testing center. At present, the company's sequencing throughput is the second in the world, and the output of tumor gene data ranks in the forefront of the country. The business covers 300+ top three hospitals in more than 30 provinces.

Yeasen Biotechnology (Shanghai) Co., Ltd. engages in the research, development, production, and sales of molecular, protein, and cell biological reagents. Its products are used in life science research, diagnosis and testing, biomedicine, and other fields. The company was founded by Wei Hua, Huang on January 9, 2014 and is headquartered in Shanghai, China.

Bio-Rad Laboratories has played a leading role in the advancement of scientific discovery for over 50 years by providing a broad range of innovative tools and services to the life science research and clinical diagnostics markets. Founded in 1952, Bio-Rad has a global team of more than 6,500 employees and serves more than 85,000 research and industry customers worldwide through its global network of operations. Throughout its existence, Bio-Rad has built strong customer relationships that advance scientific research and development efforts and support the introduction of new technology used in the growing fields of genomics, proteomics, drug discovery, food safety, medical diagnostics, and more.

Sino Mdgene is committed to providing the clinic products and services.  It has created various business segments, such as pharmacogenomics, pathogenic microbes, and tumour liquid biopsy. They offer early tumour screening, targeted drug detection for cancers, tumour drug resistance monitoring, and other services.

Precision Genomics Biotechnology focuses on the research and development of diagnostic reagents for early tumor screening. By combining genetic testing and molecular diagnostic technologies, the company develops products for liver cancer and colorectal cancer.

Biomarker Technologies provide a comprehensive genomic services consisting of science and technology, and medical technology services. Founded in 2009, Biomarker is headquartered in Beijing, China. Biomarker Technologies owns a passionate and highly-skilled R&D team of over 500 members composed of highly-educated technical staff, senior engineers, bioinformaticians and experts in diverse areas including biotechnology, agriculture, medicine, and computing.